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Lo n g it u d in a l  stu d y  o f  Ly m e  b o r r elio s is  
IN A HIGH RISK POPULATION IN SWITZERLAND
ZHIOUA E.*, **, GERN L.*, AESCHLIMANN A.*, SAUVAIN M.J.***, VAN DER LINDEN S.**** & FAHRER H.*****
Summary :
Orienteers from all parts of Switzerland (n = 416) were included 
in a longitudinal study for Lyme borreliosis. In spring 1986, the 
seroprevalence was 28.1 %. At the beginning of the study,
84.3 % of orienteers reported a history of tick bite, and 3.8 % 
reported a past history of Lyme borreliosis. During the first (spring 
1986-autumn 1986), second (autumn 1986-spring 1987) and 
third (spring 1987-autumn 1987) period, rates of seroconversion 
were 0 .6  %, 2 .7  % and 2.1 % respectively. During the first and 
second period, clinical incidence were 1.0 % and 0 .25  % 
respectively. No active Lyme borreliosis was detected during the 
third period. Among orienteers who seroconverted during the study 
(n = 16), only two developed clinical symptoms. Hence, Borrelia 
burgdorferi infection is often asymptomatic.
KEY WORDS : Borrelia burgdorferi, Ixodes ridnus, orienteers, seroprevalence, 
seroconversion, clinical incidence.
R é su m é  : Étude  prospective  de la bo rréliose  de Lyme chez une 
population  suisse  à haut risque
Des coureurs d'orientation venant de toutes les régions de Suisse 
(n = 416) ont participé à une étude prospective de la borréliose 
de Lyme. Au printemps 1986, la séroprévalence était de 28,1 %. 
Au début de l'étude, 84 ,3 % des coureurs d'orientation ont 
signalé avoir été piqués par des tiques. Durant la première 
période (printemps 1986-automne 1986), la deuxième (automne 
1986-printemps 1987) et la troisième (printemps 1987-automne 
1987), les taux de séroconversion ont été respectivement de 
0 ,6  %,  2 ,7  %, et 2,1 %. Lors des première et deuxième périodes, 
l'incidence clinique a été respectivement égale à 1,0 % et 
0 ,25  %. Aucun cas clinique n'a été observé durant la troisième 
période. Parmi les coureurs ayant présenté une séroconversion 
durant cette étude (n = 16), deux seulement ont développé des 
symptômes cliniques. Il semble donc que l'infection à Borrelia 
burgdorferi soit souvent asymptomatique.
MOTS CLÉS : Borrelia burgdorferi, Ixodes ricinus, coureurs d'orientation, 
seroprévalence, seroconversion, incidence clinique.
INTRODUCTION
L
yme borreliosis is a multisystem disorder affecting 
the skin, nervous system and joints (Steere, 1989). 
In Europe, the etiologic agent of Lyme borreliosis 
is B orrelia  bu rgdorfer i sensu lato. The former complex 
is divided into five genospecies: B. bu rgdorfer i sensu 
stricto, B. garin ii, B. afzelii, B. v a la is ian a  (formerly the 
genomic group VS116), and B. lu s itan ia e  (formerely 
the genomic group PotiB2) ; they are all transmitted by 
Ix od es  ric in u s  (Ferté et al., 1994; Péter et al., 1995; 
Zhioua et al., 1996; Postic et al., 1997). An association 
betw een different clinical manifestations o f Lyme bor­
reliosis and different species o f B. bu rgdorfer i sensu
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lato was described (Assous et al., 1993; van Dam et 
al., 1993; Balmelli & Piffaretti, 1995). The natural bio­
tope of I. ric inu s  is the forest (Aeschlimann, 1972). 
Therefore, outdoor activity for work or for leisure is 
considered to be a major risk factor for Lyme borre­
liosis. In Europe as in the USA, several cross-sectional 
studies in high risk populations showed a high sero­
prevalence and low clinical prevalence (Fahrer et al., 
1988; Gem  et al., 1989; Nadal et al., 1989; Goldstein 
et al., 1990; Zhioua et al., 1997). Longitudinal studies 
o f high risk population showed a high rate o f sero­
conversion and a low clinical incidence (Fahrer et al., 
1991; Kuiper et al., 1993; Rath et al., 1996; Schwartz 
et al., 1994). It is unknown whether or not asympto­
matic B. bu rgdorfer i infection could later develop into 
an active Lyme borreliosis. In order to answer this 
question, long-term prospective studies are required. 
However, to date, few follow-up studies o f relatively 
long duration concerning high risk populations have 
been performed in Europe.
Six months follow-up study of Lyme borreliosis among 
Swiss orienteers, a high risk population was performed 
(Fahrer et a l ,  1991). In this paper, we assess the inci­
dence of symptomatic and asymptomatic infection with 
B. burgdorferi among orienteers during a two-year study.
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MATERIALS AND METHODS
STUDY GROUP
Orienteers nm  competitively using map and compass 
in order to localize certain points in the forest. They 
were asked for blood samples and to com plete a 
questionnaire about tick exposure and possible Lyme 
borreliosis in spring 1986, autumn 1986, spring 1987, 
and autumn 1987. Three period were designed in this 
study. Periods I, II and III corresponded respectively 
to the six months from spring 1986 to autumn 1986, 
autumn 1986 to spring 1987 and spring 1987 to autumn
1987. During each blood sampling, a poster with infor­
mation on the clinical spectrum of Lyme borreliosis and 
on the vector was shown. If the answers on the ques­
tionnaire suggested possible Lyme borreliosis (e.g., 
redness o f the skin or neurologic or joint symptoms), 
further information was obtained by te lephone inter­
view. Lyme borreliosis was considered as definite if we 
received the confirmation from a physician, and pro­
bable if the description of the symptoms strongly sug­
gested Lyme borreliosis, but a physician had not been 
consulted.
C o n tr o l  g r o u p s
Semm samples were obtained from two control groups. 
Group A consisted of 51 healthy blood donors who 
live at high altitudes (> 1 000 m), where I. ric inu s  is 
rare at 1 000-1 500 m (Aeschlimann, 1972). No dem o­
graphic data w ere available concerning group A. 
Group B consisted of 50 healthy individuals (18 m ale 
and 32 female) that were not engaged in orienteering. 
The mean age in the group B was 38.1 ± 15.8 years.
S ero lo g ic a l  ASSAY
Lyme borreliosis serology was performed by ELISA as 
previously described by Fahrer et a l  (1991). The ELISA 
sonicate antigen (strain B31) was prepared according 
to the method described by Russell et al. (1984). In each 
assay, one pooled negative control serum and a diluted 
positive test serum (six times) from 1:300 to 1:9600 were 
included. The obtained curve was used as reference for 
study sera. The optical density (OD) of each sample 
was marked on this line and the resuit was expressed 
as the logarithm of the diluted (log dil) positive test 
serum. Low log dil values correspond with lesser dilu­
tion of the positive test serum represent high anti- 
B. bu rgdorfer i antibody levels. A log dil o f ≤ 3-74 (cor- 
responding to 2 SD below the mean dilution of 51 sera 
o f people living at high altitude where I. ricinus  is sup- 
posed to be absent) is the cutoff point for IgG anti- 
B. bu rgdorfer i antibodies (Fahrer et al., 1991). At this 
cut-off level, the specificity o f the test is 96 % if other 
spirochetes such as leptospires and treponemes were
excluded. The sensitivity o f the test varied from 26 % 
to 100 % depending on clinical manifestations in cases 
of definite Lyme borreliosis (Fahrer et al., 1991). 
Seroconversion was defined as a shift from negative 
to positive with a decrease o f at least 0.4 on the log 
dil (Fahrer et a l ., 1991). Seroreversion is considered as 
a shift from positive to negative.
Statistical  ANALYSIS
A contingency table was used to compare différences 
between groups.
RESULTS
Four hundred and sixteen orienteers contributed the four different blood samples types. Among them, 218 (52.4% ) were m ale  and 198 female. 
The age varied from 21 to 75 years with a mean of
54.0 (SD = 13.7).
Seroprevalence observed in the control groups A and 
B were 3 .9 % (2/51), and 6 % (3/50), respectively. Sero­
prevalence observed in orienteers in spring (1986), 
autumn (1986), spring (1987), and autumn (1987) were
28.1 % (117), 29.8 % (124), 30.3 % (126), and 29.8 % 
(124), respectively. Seroprevalence did not differ from 
spring 1986 to autumn 1987 (X2 = 0.54, P >  0.05). The 
percentages o f orienteers with seroconversion during 
the three study period were respectively 0.6 % (2/299),
2.7 % (8/292), and 2 % (6/290); no significant diffe
rence was observed among these rates (X2 = 3 .71, P >  
0.05). The percentages o f orienteers with seroreversion 
during the three study periods were 6.8 % (8/117), 
13.7 % (17/124) and 15.1 % (19/126), respectively; no 
significant difference was observed among these rates 
(X2 = 4.43, P >  0.05).
At the first b lood  sam ple (spring 1986), 84 .3  % 
(351/416) reported a history o f tick bite. The percen- 
tage of orienteers who reported a tick bite during 
period I, II, and III were 55.7 % (232), 30.0 % (125), 
and 55.7 % (232), respectively. The percentage of 
orienteers who reported a tick bite differed significantly 
among the three periods (X2 = 73-62, P  < 0.05). The 
percentage o f orienteers who reported tick bite during 
the second period was lower than the rates reported 
in the two other periods. During the three study per­
iods, 20.4 % (85/416) o f the orienteers reported a tick 
bite, and only 1.9 % (8/416) reported no tick bite. 
Hence, one fifth o f this population was repeatedly 
bitten by ticks. O f these 85 orienteers who reported a 
tick bite during the three study periods, four (4.7 %) 
had developed Lyme borreliosis in the past. None of 
the 85 orienteers developed clinical manifestations 
during the two-year investigation. Their correspon­
dent seroprevalence observed during the four blood
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* seroconversion; positive if IgG ≤ 3.74; S: spring; A: autumn; Mo: 
month; Ye: year; EM: erythema migrans; APP: atrophoderma Pie- 
rini-Pasini.
Table I. -  Clinical and serological findings of patients with active 
Lyme borreliosis during the two-year survey.
samples were 32.9 % (28), 32.9 % (28), 32.9 % (28) 
and 35.3 % (30), respectively.
On the basis o f the questionnaire, 16 orienteers repor­
ted a history o f Lyme borreliosis (eight definite and 
eight probable). Therefore, the clinical prevalence was
3.8 % ( 16/416). In this group, the frequency of Ery­
thema Migrans (EM) was 68.7 % (11/16). Neurological 
and articular symptoms were less frequently observed 
(37.5 % = 6/16).
During period I, the clinical incidence was 1.0 % 
(4/400) (Table I, patient no. 1 to 4). During period II, 
only one EM was observed (Table I, patient no. 5); 
hence, the clinical incidence during this period was 
0.25 % (1/396). All clinical cases observed during the 
two-year study were definite. No clinical case was 
observed during period III. No significant difference 
was observed betw een these clinical incidence (Fisher 
exact test, P = 0.12). The annual incidence (spring 
1986-spring 1987) was 1.25 % (5/400).
During the two year follow-up study, 16 orienteers 
showed seroconversion. Among them, only two deve- 
loped clinical symptoms (Table I, patients no. 4 and 
5). Patient no. 2 (Table I) who was seropositive in 
spring 1986 developed EM later in autumn 1986.
DISCUSSION
The percentage of orienteers with a history o f a tick bite is high and varies significantly with season of tick activity. Therefore, orienteers are 
considered as a high risk population because o f their 
high exposure to tick bites. A longitudinal study per­
formed on a population at risk in Germany showed 
that 53.8 % of forestry workers reported a history of 
tick bites at the beginning o f the study; six months 
later, 32.7 % of participants reported a tick bite during 
this interval (Rath et al. 1996). Similar findings were 
reported in Sweden, where more than 30 % of parti­
cipants reported a history of tick a bite each year (Gus­
tafson et al., 1992).
In Switzerland, the infection rate o f I. ric in u s  with 
B. bu rgdorfer i varies from 5 to 35 % (Aeschlimann et 
al., 1986). Due to the high frequency of orienteers with 
a tick bite history, a high seroprevalence among this 
population was expected. Seroprevalence and sero­
conversion observed in orienteers remained stable over 
a two-year follow-up period. A comparable study on 
a high risk population from Sweden showed that the 
seroprevalence and the seroconversion remained stable 
over a two-year follow-up period (Gustafson et al., 
1992). Seroprevalence observed in 1987, 1988, and 
1989 were 25.7 %, 26.4 %, and 29.2 %, respectively 
(Gustafson et al., 1992). Seroconversion observed in 
first year and the second year were 4.6 %, and 2.9 % ,- 
respectively (Gustafson et al., 1992). However, in the 
USA, one longitudinal study on outdoor workers (New 
Jersey) showed that seroprevalence and seroconversion 
fluctuated significantly with time (Schwartz et al., 1994). 
Seroprevalence reached a peak of 18.7 % in 1990 
before decreasing to 4.4 % in 1991 (Schwartz et al.,
1994). Seroconversion observed in 1989, 1990, and 1991 
were 6.8 %, 16.7 %, and 0.6 %, respectively (Schwartz 
et al., 1994). The significant decrease in seroprevalence 
and seroconversion observed in outdoor workers was 
attributed partly to the probable benefit o f ongoing 
educational programs and systematic treatment o f all 
seropositives (Schwartz e t  al., 1994).
The present study showed that 12.5 % (2/16) o f orien­
teers with seroconversion, developed clinical symp­
toms. Similar findings were observed in Sweden; only
9.1 % (2/22) of individuals with seroconversion showed 
clinical manifestations (Gustafson et al., 1992). In the 
Netherlands, 5 % of forestry workers showed asymp- 
tomatic seroconversion (Kuiper et al. 1993). In Ger­
many, seroconversion was observed among 7.2 % of 
forestry workers; none had developed clinical symp­
toms (Rath et al. 1996). The majority o f seroconver­
sion observed in New Jersey  w ere asymptomatic 
(Schwartz et al. 1994). Therefore, B. bu rgdorfer i infec­
tion is often asymptomatic.
The annual clinical incidence observed among orien­
teers in Switzerland (1.25 %) was within the range 
reported from other European countries: 0 % in Ger­
many (Rath et al. 1996); 0 % in the Netherlands (Kuiper 
et al. 1993), and 2.9 % in Sweden (Gustafson et al. 
1992). This figure is also similar to the annual incidence 
reported in two studies in the USA which ranged from 
0 to 3-3 % (Hanrahan et al., 1984; Steere et al., 1986). 
During the two-year survey, no clinical symptoms 
were observed among the majority o f orienteers with 
seroconversion and among almost all those seroposi­
tive at the time of the first blood sample without a his­
tory o f Lyme borreliosis. B orrelia  bu rgdorfer i infection 
is frequent among orienteers, but seems to take a 
benign course.
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